ANIP  valuation analysis

Basics
Name: ANI Pharmaceuticals Inc
Description: ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 01, 2021
Market cap: $595.91M (1338th)
Sales(TTM): $212.46M (1342nd)
Earnings(TTM): -$22.10M (1251st)

Value
FFER: 1.06 (why)
Actual price: $49.22
FFEThis is ANI Pharmaceuticals Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $46.62
Quantile: ANIP is priced correctly given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
ANI Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
ANI Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
ANI Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
ANI Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry